Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 868,520 | 1,028,410 | 948,050 | 1,037,400 | N/A |
| Marketable Securities | 196,380 | 218,570 | 436,400 | 496,420 | N/A |
| Receivables | 349,670 | 414,110 | 461,030 | 516,510 | N/A |
| Inventories | 215,030 | 237,560 | 249,030 | 227,290 | N/A |
| Other current assets | 19,270 | 18,280 | 189,970 | 188,670 | 0 |
| TOTAL | $1,648,870 | $1,916,930 | $2,284,480 | $2,466,290 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 589,610 | 579,870 | 527,970 | 585,120 | N/A |
| Investments And Advances | 1,829,150 | 1,856,540 | 1,917,020 | 2,057,200 | 0 |
| Other Non-Current Assets | 303,910 | 410,960 | 117,010 | 213,490 | 0 |
| TOTAL | $2,722,670 | $2,847,370 | $2,562,000 | $2,855,810 | $N/A |
| Total Assets | $4,371,560 | $4,764,330 | $4,846,520 | $5,322,120 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 4,980 | 1,100 | 20 | N/A |
| Accounts payable and accrued liabilities | 114,540 | 106,230 | 45,140 | 70,320 | 0 |
| Accrued Expenses | 0 | 0 | 157,050 | 178,420 | N/A |
| Other current liabilities | 119,810 | 119,340 | 11,380 | 21,530 | N/A |
| TOTAL | $291,640 | $272,740 | $274,320 | $378,560 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,640 | 4,580 | 1,870 | 130 | N/A |
| Other Non-Current Liabilities | 107,530 | 7,160 | 13,280 | 21,950 | 0 |
| TOTAL | $119,800 | $60,240 | $69,080 | $53,700 | $N/A |
| Total Liabilities | $411,450 | $333,000 | $343,420 | $432,260 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 530,106 |
| Common Shares | 144,650 | 170,170 | 184,660 | 211,680 | N/A |
| Retained earnings | 3,747,410 | 4,478,520 | 4,583,230 | 5,192,520 | N/A |
| Other shareholders' equity | 419,720 | 196,190 | 183,500 | -640 | 0 |
| TOTAL | $3,960,110 | $4,431,330 | $4,503,090 | $4,889,850 | $N/A |
| Total Liabilities And Equity | $4,371,560 | $4,764,330 | $4,846,510 | $5,322,110 | $0 |